Viatris (VTRS) Other Non Operating Income (2019 - 2026)

Viatris' (VTRS) quarterly Other Non Operating Income came in at -$47.5 million in Q1 2026, up 52.17% year-on-year from -$31.2 million in Q1 2025, and down 54.72% quarter-over-quarter from -$30.7 million in Q4 2025.

Viatris (VTRS) Other Non Operating Income (2019 - 2026) Analysis & Trends

Viatris' Other Non Operating Income history runs 8 years deep, the most recent figure standing at -$47.5 million for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 52.17% year-over-year to -$47.5 million in Q1 2026; TTM through Mar 2026 was -$478.8 million, a 421.57% decrease from a year earlier, with the FY2025 full-year figure at -$530.6 million, down 536.97% from the prior year.
  • Other Non Operating Income slipped to -$47.5 million in Q1 2026 per VTRS's latest filing, from -$30.7 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.8 billion in Q4 2022 and bottomed at -$333.5 million in Q2 2025.
  • The 5-year median for Other Non Operating Income is -$6.1 million (2024), against an average of $80.5 million.
  • Across the five-year window, Other Non Operating Income surged 8198.17% in 2022 and sank 5367.21% in 2025, its largest moves.
  • Year by year, Other Non Operating Income stood at $1.8 billion in 2022, then sank by 114.28% to -$259.6 million in 2023, then surged by 101.31% to $3.4 million in 2024, then tumbled by 1002.94% to -$30.7 million in 2025, then plunged by 54.72% to -$47.5 million in 2026.
  • Per Business Quant, the three latest VTRS Other Non Operating Income figures stand at -$47.5 million (Q1 2026), -$30.7 million (Q4 2025), and -$67.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -47.50 Mn
Dec 31, 2025 -30.70 Mn
Sep 30, 2025 -67.10 Mn
Jun 30, 2025 -333.50 Mn
Mar 31, 2025 -99.30 Mn
Dec 31, 2024 3.40 Mn
Sep 30, 2024 10.20 Mn
Jun 30, 2024 -6.10 Mn
Mar 31, 2024 139.10 Mn
Dec 31, 2023 -259.60 Mn
Sep 30, 2023 92.00 Mn
Jun 30, 2023 107.50 Mn
Mar 31, 2023 69.90 Mn
Dec 31, 2022 1.82 Bn
Sep 30, 2022 20.60 Mn
Jun 30, 2022 -13.50 Mn
Mar 31, 2022 -33.70 Mn
Dec 31, 2021 21.90 Mn
Sep 30, 2021 -5.80 Mn
Jun 30, 2021 -4.20 Mn